BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Overview
- 100–199
- Employees
- 20–50M SEK
- Revenue
- 1997
- Founded
Key Decision Makers
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
+19 more contacts in Funnelfeedr
Description
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Bioteknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556537726301
Decision Makers
23 contacts in FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Vincent Ossipow
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Other Contacts
Marina Mangold
Data Protection Officer
Mona Welschof
Clinical Operations
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Similar Companies
20 similar companies in FunnelfeedrAlligator Bioscience AB
10–19 employeesClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 employeesDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 employeesDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Browse More
BioInvent International Aktiebolag Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo